Role of the Functional Toll-Like Receptor-9 Promoter Polymorphism (-1237T/C) in Increased Risk of End-Stage Renal Disease: A Case-Control Study

• Hsin-Yi Yang,

  Affiliation School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China

  ⨯
• Kuo-Cheng Lu,

  Affiliation Division of Nephrology, Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan, Republic of China

  ⨯
• Herng-Sheng Lee,

  Affiliation Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China

  ⨯
• Shih-Ming Huang,

  Affiliation Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China

  ⨯
• Yuh-Feng Lin,

  Affiliations Division of Nephrology, Department of Medicine, Shuang Ho Hospital, Graduate Institute of Clinical Medicine, Taipei Medical University, New Taipei City, Taiwan, Republic of China, Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China

  ⨯
• Chia-Chao Wu,

  Affiliation Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China

  ⨯
• Donald M. Salter,

  Affiliation Center for Molecular Medicine, MRC IGMM, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Sui-Lung Su

  * E-mail: a131419@gmail.com

  Affiliation School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China

  ⨯